Catalent | CTLT - Собственный капитал и резервы



Собственный капитал и резервы Изменить Дата
Agilent USD 6.91B 167M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Bruker USD 2.49B 625.6M 2025-09
Centene USD 19.95B 995M 2025-12
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cigna USD 41.71B 92M 2025-12
Danaher USD 52.53B 1.46B 2025-12
Dentsply International USD 1.34B 139M 2025-12
Elevance Health USD 44.03B 73M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Humana USD 17.66B 865M 2025-12
Illumina USD 2.72B 342M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
J&J USD 78.47B 0 2025-09
Laboratory Of America USD 8.62B 93.2M 2025-12
Lonza CHF 9.13B 513M 2025-12
McKesson USD -1.3B 441M 2025-12
Merck EUR 28.59B 344M 2025-12
Merck USD 51.85B 2.79B 2025-09
Mettler Toledo International USD -23.64M 225.56M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Quest Diagnostics USD 7.17B 88M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
UnitedHealth USD 105.81B 1.03B 2025-09
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 2.56B 230.55M 2025-12
West Pharmaceutical Services USD 3.18B 124.5M 2025-12